Skip to main content

Table 1 Measurements of the effect of human lysozyme (hLz), lactoferrin (hLf), β defensin-1 (HBD-1) and β defensin-2 (HBD-2) on the growth of otitis media pathogens, using the radial inhibition assay.

From: Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae

  

Bacteria

Molecule

Total amount of protein/peptide added (in a total volume of 4 μl)

NTHi

M. catarrhalis

S. pneumoniae 3

S. pneumoniae 6B

hLz

50 μg

-

4.6 ± 0.4 (P)

6.2 ± 0.7 (C)

6.7 ± 0.9 (C)

 

100 μg

-

5.6 ± 0.7 (P)

7.2 ± 0.5 (C)

7.4 ± 0.6 (C)

 

200 μg

-

6.2 ± 0.5 (P)

7.7 ± 0.6 (C)

8.2 ± 0.7 (C)

hLf

4 μg

-

-

-

-

 

10 μg

E

-

E

-

 

40 μg

E

E

E

E

HBD-1

4 μg

-

-

-

-

 

10 μg

-

7.7 ± 0.6 (P)

-

-

 

40 μg

ND

ND

ND

ND

HBD-2

4 μg

9.7 ± 2.5 (C)

11.7 ± 0.6 (C)

8.7 ± 1.5 (C)

8.7 ± 1.2 (C)

 

10 μg

12.3 ± 2.9 (C)

14.7 ± 0.6 (C)

10 ± 1.3 (C)

10.7 ± 1.5 (C)

 

40 μg

ND

ND

ND

ND

  1. Diameter (mm) of the inhibition zone (average of 3 separate experiments ± SD) caused by the different concentrations of the antimicrobial molecules is given in the column below each pathogen. -: No effect; E: Enhanced growth; C: Complete inhibition; P: Partial inhibition; ND: Not done